A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03774784

Recruitment Status : Terminated (The study was terminated due to the impacts of COVID-19 on patient safety and enrollment.)

First Posted : December 13, 2018

Last Update Posted : June 16, 2020

Sponsor:

Information provided by (Responsible Party):

Alnylam Pharmaceuticals

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	May 18, 2020
Actual Study Completion Date :	May 18, 2020

To Top